ScanSource (SCSC) Q3 2026 Margin Holds At 2.4% Challenging Bullish Expansion Narratives

ScanSource, Inc.

ScanSource, Inc.

SCSC

0.00

Q3 2026 Results Snapshot

ScanSource (SCSC) has reported Q3 2026 revenue of US$766.8 million and basic EPS of US$0.79, supported by net income of US$16.9 million. This gives investors a clear read on the quarter’s top and bottom lines. Over the past six quarters, the company’s quarterly revenue has moved between US$704.8 million and US$812.9 million. Over the same period, basic EPS has ranged from US$0.72 to US$0.90, with net income between US$16.5 million and US$20.1 million. This frames Q3 within a relatively tight band of recent performance. With trailing twelve month net profit margin at 2.4% compared with 2.3% a year earlier, the emphasis this quarter is on how small shifts in profitability shape the risk and reward profile for holders.

See our full analysis for ScanSource.

With the latest figures available, the next step is to see how these margins and earnings trends align with the prevailing narratives around ScanSource or prompt investors to reassess the story.

NasdaqGS:SCSC Revenue & Expenses Breakdown as at May 2026
NasdaqGS:SCSC Revenue & Expenses Breakdown as at May 2026

TTM profitability edges up to 2.4% margin

  • On a trailing twelve month view, net income of US$73.3 million on US$3.1b of revenue gives ScanSource a 2.4% net margin, slightly above the 2.3% margin reported a year earlier.
  • What bullish investors point to is that this 2.4% margin sits alongside five year earnings growth of 9.6% per year. They argue this can be supported by higher margin offerings and acquisitions, while the flat quarterly net income range of roughly US$16.5 million to US$20.1 million shows how much work is needed if margin expansion is going to meaningfully shift overall profitability.
    • Supporters of the bullish view often cite the move toward more recurring and higher margin revenue. Yet the latest quarterly net income of US$16.9 million still sits inside the same band as the prior six quarters.
    • With trailing EPS at US$3.34 and Q3 EPS at US$0.79, bulls suggest operational changes could lift each quarter closer to the trailing run rate. However, the recent data is still clustered rather than breaking out.
On the bullish side, some investors see the steady 2.4% margin and five year earnings growth as a base for stronger profit compounding if higher margin services keep gaining share. They track how quickly quarterly net income can move beyond the recent US$16 million to US$20 million range to support that view. 🐂 ScanSource Bull Case

P/E of 12.7x vs industry at 27.7x

  • The trailing P/E of 12.7x sits below the US Electronic industry average of 27.7x, the broader US market at 19.3x, and ScanSource's peer average of 14.6x, pointing to lower earnings multiples over the last year.
  • Critics taking the bearish narrative highlight that even with this lower 12.7x P/E, forecasts for revenue growth at 3.7% per year and earnings growth at 12.2% per year both sit below the US market forecasts of 11.4% and 16.4% respectively. They therefore question whether the discount is simply the market adjusting for slower expected growth.
    • The bearish view notes that while earnings have grown 9.6% per year over five years, that pace still trails the 16.4% earnings growth forecast cited for the wider market, which they see as limiting any case for a much higher multiple.
    • They also point out that the current share price of US$43.40 is already close to the allowed analyst target of US$51.67. This narrows the numerical gap between where the stock trades and that specific target.
Skeptical investors argue that a 12.7x P/E only looks cheap next to higher industry multiples if ScanSource can close the growth gap with the wider market. They watch how actual revenue and EPS trends stack up against those 3.7% and 12.2% forecasts before re-rating the stock. 🐻 ScanSource Bear Case

DCF fair value trails share price

  • The current share price of US$43.40 sits above the provided DCF fair value of US$33.78, creating a gap of around US$9.62 per share between market price and that intrinsic value estimate.
  • What stands out when testing the bullish story against this is that, even with multi year earnings growth of 9.6% and a trailing net margin of 2.4%, the DCF input set still points to a lower fair value. At the same time, the relatively low 12.7x P/E multiple and earnings growth forecasts of 12.2% per year give bulls numerical support for arguing that the stock is valued more like a slower grower despite that history.
    • Supporters of the bullish angle might see the P/E discount versus the 27.7x industry average as the market underestimating the impact of past and expected earnings growth. The DCF fair value of US$33.78 directly challenges that by implying less generous long term cash flow assumptions.
    • For a beginner investor, the key tension is that one set of numbers, the P/E comparisons, suggests relative value, while another set, the DCF fair value versus the US$43.40 share price, suggests a more conservative view of upside based purely on cash flow estimates.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for ScanSource on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

The mix of bullish and bearish signals in this update is clear, so now is a good time to review the numbers yourself and decide where you stand. You can start with the 4 key rewards and 1 important warning sign.

See What Else Is Out There

ScanSource's tight net income band, modest 2.4% margin and higher share price than the DCF fair value all point to limited value support right now.

If you want ideas where pricing looks more supportive, check out 49 high quality undervalued stocks and quickly compare stocks that may offer a stronger value case.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.